Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Efficacy of treatment intensification with adalimumab, etanercept and infliximab in rheumatoid arthritis: a systematic review of cohort studies with focus on dose

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{7ea302b00e5b4863bd574a686d084706,
title = "Efficacy of treatment intensification with adalimumab, etanercept and infliximab in rheumatoid arthritis: a systematic review of cohort studies with focus on dose",
abstract = "To summarize the empirical evidence regarding the effect of treatment intensification on clinical outcomes in patients with rheumatoid arthritis treated with one of the TNF-α-inhibitors, adalimumab, etanercept or infliximab.",
author = "Grith Eng and Stoltenberg, {Michael B} and Marcin Szkudlarek and Bouchelouche, {Pierre N} and Robin Christensen and Henning Bliddal and {Marie Bartels}, Else",
note = "Copyright {\circledC} 2013 Elsevier Inc. All rights reserved.",
year = "2013",
month = "10",
doi = "10.1016/j.semarthrit.2013.01.007",
language = "English",
volume = "43",
pages = "144--51",
journal = "Seminars in Arthritis and Rheumatism",
issn = "0049-0172",
publisher = "W.B./Saunders Co",
number = "2",

}

RIS

TY - JOUR

T1 - Efficacy of treatment intensification with adalimumab, etanercept and infliximab in rheumatoid arthritis

T2 - a systematic review of cohort studies with focus on dose

AU - Eng, Grith

AU - Stoltenberg, Michael B

AU - Szkudlarek, Marcin

AU - Bouchelouche, Pierre N

AU - Christensen, Robin

AU - Bliddal, Henning

AU - Marie Bartels, Else

N1 - Copyright © 2013 Elsevier Inc. All rights reserved.

PY - 2013/10

Y1 - 2013/10

N2 - To summarize the empirical evidence regarding the effect of treatment intensification on clinical outcomes in patients with rheumatoid arthritis treated with one of the TNF-α-inhibitors, adalimumab, etanercept or infliximab.

AB - To summarize the empirical evidence regarding the effect of treatment intensification on clinical outcomes in patients with rheumatoid arthritis treated with one of the TNF-α-inhibitors, adalimumab, etanercept or infliximab.

U2 - 10.1016/j.semarthrit.2013.01.007

DO - 10.1016/j.semarthrit.2013.01.007

M3 - Journal article

VL - 43

SP - 144

EP - 151

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

SN - 0049-0172

IS - 2

ER -

ID: 42570271